Expression and purification of Steroidogenic Factor-1 (NR5A1) nuclear receptor ligand binding domain complexed with the signaling phosphoinositide lipid PI(3,4,5)P3
Methods in Enzymology · 2026
DOI: 10.1016/bs.mie.2026.01.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2026. Verfasst von Alexis N Campbell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States. Hauptthemen laut MEDLINE: Steroidogenic Factor 1, Phosphatidylinositol Phosphates. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Steroidogenic Factor-1 (SF-1, NR5A1) is an orphan nuclear receptor that plays a critical role in proper development and adult function of the adrenals, gonads and the ventral medial hypothalamus in the brain. Structural studies have revealed that the SF-1 ligand-binding domain is capable of interaction with glycerophospholipids, such as phosphoinositides, in its binding pocket. Of these, the phosphoinositide PI(3,4,5)P3 (PIP3) has a high affinity for SF-1 and functions as a key regulatory ligand. This paper details the methods for the recombinant expression and purification of the SF-1 protein, as well as a novel protocol for isolating pure SF-1 bound to PIP3. These methods are a foundational step for future biophysical assays, crystallography studies, and the development of targeted therapeutics for SF-1-dependent adrenocortical carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States.
- Division of Diabetes, Department of Medicine, Endocrinology & Metabolism, Vanderbilt University Medical Center, Nashville, TN, United States.
- Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States; Division of Diabetes, Department of Medicine, Endocrinology & Metabolism, Vanderbilt University Medical Center, Nashvil…
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Campbell, A. N., Cutright, A. J., Martin, J., Kheda, A., Loi, M. N. C., & Blind, R. D. (2026). Expression and purification of Steroidogenic Factor-1 (NR5A1) nuclear receptor ligand binding domain complexed with the signaling phosphoinositide lipid PI(3,4,5)P3. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2026.01.014
Vancouver
Campbell AN, Cutright AJ, Martin J, Kheda A, Loi MNC, Blind RD. Expression and purification of Steroidogenic Factor-1 (NR5A1) nuclear receptor ligand binding domain complexed with the signaling phosphoinositide lipid PI(3,4,5)P3. Methods in Enzymology. 2026. doi:10.1016/bs.mie.2026.01.014
BibTeX
@article{Campbell2026,
author = {Campbell, Alexis N and Cutright, Alexander J and Martin, Jessica and Kheda, Arwa and Loi, Mong Na Claire and Blind, Raymond D},
title = {Expression and purification of Steroidogenic Factor-1 (NR5A1) nuclear receptor ligand binding domain complexed with the signaling phosphoinositide lipid PI(3,4,5)P3},
journal = {Methods in Enzymology},
year = {2026},
doi = {10.1016/bs.mie.2026.01.014}
}
EUVIMED